CoChat

Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes

Open access

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

In vitro models that better reflect in vivo epithelial barrier (patho-)physiology are urgently required to predict adverse drug effects. Here we introduce extracellular matrix-supported intestinal tubules in perfused microfluidic devices, exhibiting tissue polarization and transporter expression. Forty leak-tight tubules are cultured in parallel on a single plate and their response to pharmacological stimuli is recorded over 125 h using automated imaging techniques. A study comprising 357 gut tubes is performed, of which 93% are leak tight before exposure. EC 50 -time curves could be extracted that provide insight into both concentration and exposure time response. Full compatibility with standard equipment and user-friendly operation make this Organ-on-a-Chip platform readily applicable in routine laboratories.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00259-3

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Overview of the method for modeling intestinal tubules in the OrganoPlate platform. a Photograph of the bottom of an OrganoPlate showing 40 microfluidic channel networks with inlay showing the top view of the 384-well plate format device; b Zoom-in on a single microfluidic channel network comprising three channels that join in the center. c, e, g, i Horizontal projection and d, f, h, j vertical cross section of center region for subsequent steps in establishing the gut model. c, d An extracellular matrix gel (light gray) is patterned by two phaseguides (dark gray), e, f culture medium is introduced in the two lanes adjacent to the ECM gel, one of which comprises cells. g, h Cells are allowed to settle against the ECM gel surface by placing the plate on its side. i, j Upon application of flow, cells form a confluent layer lining the channel and gel surfaces, resulting in a tubular shape. k 3D artist impression of the center of a chip comprising a tubule, an extra cellular matrix gel and a perfusion lane; two phaseguides (white bars) are present that define the three distinct lanes in the central channel. The tubule has a lumen at its apical side that is perfused. l–p Phase-contrast images of the formation of the tubular structure at day 0, 1, 4, 7, and 11, respectively. Scale bars are 100 µm
Fig. 1 Overview of the method for modeling intestinal tubules in the OrganoPlate platform. a Photograph of the bottom of an OrganoPlate showing 40 microfluidic channel networks with inlay showing the top view of the 384-well plate format device; b Zoom-in on a single microfluidic channel network comprising three channels that join in the center. c, e, g, i Horizontal projection and d, f, h, j vertical cross section of center region for subsequent steps in establishing the gut model. c, d An extracellular matrix gel (light gray) is patterned by two phaseguides (dark gray), e, f culture medium is introduced in the two lanes adjacent to the ECM gel, one of which comprises cells. g, h Cells are allowed to settle against the ECM gel surface by placing the plate on its side. i, j Upon application of flow, cells form a confluent layer lining the channel and gel surfaces, resulting in a tubular shape. k 3D artist impression of the center of a chip comprising a tubule, an extra cellular matrix gel and a perfusion lane; two phaseguides (white bars) are present that define the three distinct lanes in the central channel. The tubule has a lumen at its apical side that is perfused. l–p Phase-contrast images of the formation of the tubular structure at day 0, 1, 4, 7, and 11, respectively. Scale bars are 100 µmCC BY · PubMed Central
Fig. 2 Tubule characterization by immunofluorescent staining. a 3D reconstruction of a confocal z-stack showing tubular morphology with a lumen. White arrows indicate the apical (A) and basal (B) sides. The tube is stained for tight junctions (ZO-1 in red) and brush borders (ezrin in green). b Max projection and c vertical cross-section of the tubular structure in a; d, e zoom of the epithelial layer at the bottom of the tube exhibiting d tight junctions (ZO-1 in red) and brush borders (ezrin in green), and e acetylated tubulin (green) and occluding (red). f Phase-contrast image showing dome formation. g Zoom of a z-slice of the tube in a of the cell layer on top of the phaseguide showing apical positioning of ezrin, indicating polarization of the tube (white arrow indicates basal side B). h Expression of glucose and MRP2 transporters, respectively stained with Glut-2 in red and MRP2 stain in green. Both Glut-2 and MRP2 show significantly higher signal against the collagen gel compared to the regions that are not exposed to the collagen, indicating increased expression levels. Both stains clearly stain the apical side of the tube. For z-slices above the phaseguide at a higher magnification see Supplementary Fig. 2b. i ErbB1 (red) and acetylated tubulin (green) expression. ErbB1 expression levels appear higher against the collagen. j Co-staining of Glut-2 transporter and ErbB2 receptor; both stains show higher signal levels against the collagen gel. ErbB2 is primarily expressed pericellularly (see also Supplementary Fig. 2d for a zoom)). All tubes are fixed after 4 days in culture. Nuclei are stained blue with Draq5 (a–c, g–j) and DAPI (d, e). Scale bars in white are 100 µm with the exception of d, e, f, and g, where they are 50 µm. Z-slices just above the phaseguide at higher magnification of the images g–j are available in Supplementary Fig. 2. All images are representative of at least three biological and at least three technical replicates
Fig. 2 Tubule characterization by immunofluorescent staining. a 3D reconstruction of a confocal z-stack showing tubular morphology with a lumen. White arrows indicate the apical (A) and basal (B) sides. The tube is stained for tight junctions (ZO-1 in red) and brush borders (ezrin in green). b Max projection and c vertical cross-section of the tubular structure in a; d, e zoom of the epithelial layer at the bottom of the tube exhibiting d tight junctions (ZO-1 in red) and brush borders (ezrin in green), and e acetylated tubulin (green) and occluding (red). f Phase-contrast image showing dome formation. g Zoom of a z-slice of the tube in a of the cell layer on top of the phaseguide showing apical positioning of ezrin, indicating polarization of the tube (white arrow indicates basal side B). h Expression of glucose and MRP2 transporters, respectively stained with Glut-2 in red and MRP2 stain in green. Both Glut-2 and MRP2 show significantly higher signal against the collagen gel compared to the regions that are not exposed to the collagen, indicating increased expression levels. Both stains clearly stain the apical side of the tube. For z-slices above the phaseguide at a higher magnification see Supplementary Fig. 2b. i ErbB1 (red) and acetylated tubulin (green) expression. ErbB1 expression levels appear higher against the collagen. j Co-staining of Glut-2 transporter and ErbB2 receptor; both stains show higher signal levels against the collagen gel. ErbB2 is primarily expressed pericellularly (see also Supplementary Fig. 2d for a zoom)). All tubes are fixed after 4 days in culture. Nuclei are stained blue with Draq5 (a–c, g–j) and DAPI (d, e). Scale bars in white are 100 µm with the exception of d, e, f, and g, where they are 50 µm. Z-slices just above the phaseguide at higher magnification of the images g–j are available in Supplementary Fig. 2. All images are representative of at least three biological and at least three technical replicatesCC BY · PubMed Central
Fig. 3 Barrier integrity assay in OrganoPlate. A fluorescent dye is inserted in the channel comprising the tube. Integrity of the tube barrier is quantified by measuring the amount of dye that is leaking out of the tube into the adjacent gel channel. a–c Sketch in vertical cross section showing fluorescence distribution: a in absence of a tube, b for the case of a leak-tight tube and c for a leaky tube. d–i Fluorescent images of microfluidic chips perfused with fluorescent molecules show experimental results for: gel only (d, g), leak-tight tube (e, h), and leaky tube (f–i) using both 150 kDa FITC-dextran and 4.4 kDa TRITC-Dextran during the same experiment
Fig. 3 Barrier integrity assay in OrganoPlate. A fluorescent dye is inserted in the channel comprising the tube. Integrity of the tube barrier is quantified by measuring the amount of dye that is leaking out of the tube into the adjacent gel channel. a–c Sketch in vertical cross section showing fluorescence distribution: a in absence of a tube, b for the case of a leak-tight tube and c for a leaky tube. d–i Fluorescent images of microfluidic chips perfused with fluorescent molecules show experimental results for: gel only (d, g), leak-tight tube (e, h), and leaky tube (f–i) using both 150 kDa FITC-dextran and 4.4 kDa TRITC-Dextran during the same experimentCC BY · PubMed Central
Fig. 4 Drug-induced loss of barrier integrity is observed over time in a concentration-dependent manner. Results shown for staurosporine (a, b, e–g) and aspirin (c, d, h–j). a–d Array of fluorescence micrographs of the gel region showing distribution of the 150 kDa FITC-Dextran (a, c), and 4.4 kDa TRITC-Dextran (b, d) over time and for various compound concentrations; the loss of barrier integrity results in an increased fluorescent signal. Measurements are taken at 1-h intervals up to 12 h, at 16 h, from 24 to 36 h at 1 h interval, and at 48, 53, 60, 72, 82, 96, and 125 h. In between each interval, the OrganoPlate was placed back into the incubator on the interval rocker platform to maintain the perfusion flow. Five technical replicates of each concentration of a compound were measured on a single plate. One well was excluded from further data analysis, because of a pipetting error (marked with “excl” in white). e, h The progression of the loss of barrier function over time is plotted as the ratio between fluorescent signal in apical and basal regions for the various concentrations of staurosporine (e) and aspirin (h), where the plotted line is the mean of five replicate exposures and error bars depict the standard deviation. f, i Kaplan–Meier curves were generated where survival was defined as showing a leakage score below 40%. Overlapping curves were shifted by 1% for clarity purposes. g, j EC50 values are plotted as a function of exposure time. EC50 values were obtained by fitting a concentration-response curve at each time point based on non-linear regression of leakage scores using normalized response and standard slope and were plotted including 95% confidence interval (CI). EC50 values obtained from time points before the first event in the Kaplan–Meier plot, as indicated by a grayed out line, should be interpreted with caution as the curve fit could be dominated by noise rather than biological effect. All shown graphs were derived from data acquired using 150 kDa FITC dextran. Technical replicates are defined as tubes seeded on the same plate and exposed in the same experimental session. Independent full replicate series were run for both staurosporine and aspirin that are displayed in Supplementary Figs. 3 and 4
Fig. 4 Drug-induced loss of barrier integrity is observed over time in a concentration-dependent manner. Results shown for staurosporine (a, b, e–g) and aspirin (c, d, h–j). a–d Array of fluorescence micrographs of the gel region showing distribution of the 150 kDa FITC-Dextran (a, c), and 4.4 kDa TRITC-Dextran (b, d) over time and for various compound concentrations; the loss of barrier integrity results in an increased fluorescent signal. Measurements are taken at 1-h intervals up to 12 h, at 16 h, from 24 to 36 h at 1 h interval, and at 48, 53, 60, 72, 82, 96, and 125 h. In between each interval, the OrganoPlate was placed back into the incubator on the interval rocker platform to maintain the perfusion flow. Five technical replicates of each concentration of a compound were measured on a single plate. One well was excluded from further data analysis, because of a pipetting error (marked with “excl” in white). e, h The progression of the loss of barrier function over time is plotted as the ratio between fluorescent signal in apical and basal regions for the various concentrations of staurosporine (e) and aspirin (h), where the plotted line is the mean of five replicate exposures and error bars depict the standard deviation. f, i Kaplan–Meier curves were generated where survival was defined as showing a leakage score below 40%. Overlapping curves were shifted by 1% for clarity purposes. g, j EC50 values are plotted as a function of exposure time. EC50 values were obtained by fitting a concentration-response curve at each time point based on non-linear regression of leakage scores using normalized response and standard slope and were plotted including 95% confidence interval (CI). EC50 values obtained from time points before the first event in the Kaplan–Meier plot, as indicated by a grayed out line, should be interpreted with caution as the curve fit could be dominated by noise rather than biological effect. All shown graphs were derived from data acquired using 150 kDa FITC dextran. Technical replicates are defined as tubes seeded on the same plate and exposed in the same experimental session. Independent full replicate series were run for both staurosporine and aspirin that are displayed in Supplementary Figs. 3 and 4CC BY · PubMed Central
Fig. 5 Drug-induced loss of barrier integrity as a function of staurosporine concentration measured in real-time. a, b Array of fluorescence micrographs of the gel region showing distribution of the 150 kDa FITC-Dextran (a) and 4.4 kDa TRITC-Dextran (b) over time and as a function of compound concentration; the OrganoPlate was continuously kept in an incubated automated microscope. Pictures were taken at 1 h intervals. One data point was excluded for the fact that the tube appeared leaky at the first time point (marked with “excl” in white). c The progression of the loss of barrier function over time shows that untreated controls lose barrier integrity at 6–8 h due to lack of flow. The plotted line is the mean of 3–5 technical replicate exposures and error bars depict the standard deviation. d EC50 values over time for real-time measurement without flow and for measurement in intervals with flow induced between measurement (overlay with the graph of Fig. 4g). EC50 values with and without flow are similar for the initial 8 h of measurement
Fig. 5 Drug-induced loss of barrier integrity as a function of staurosporine concentration measured in real-time. a, b Array of fluorescence micrographs of the gel region showing distribution of the 150 kDa FITC-Dextran (a) and 4.4 kDa TRITC-Dextran (b) over time and as a function of compound concentration; the OrganoPlate was continuously kept in an incubated automated microscope. Pictures were taken at 1 h intervals. One data point was excluded for the fact that the tube appeared leaky at the first time point (marked with “excl” in white). c The progression of the loss of barrier function over time shows that untreated controls lose barrier integrity at 6–8 h due to lack of flow. The plotted line is the mean of 3–5 technical replicate exposures and error bars depict the standard deviation. d EC50 values over time for real-time measurement without flow and for measurement in intervals with flow induced between measurement (overlay with the graph of Fig. 4g). EC50 values with and without flow are similar for the initial 8 h of measurementCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 315

Metadata

Authors
Trietsch, S. J., Naumovska, E., Kurek, D., Setyawati, M. C., Vormann, M. K., Wilschut, K. J., Lanz, H. L., Nicolas, A., Ng, C. P., Joore, J., Kustermann, S., Roth, A., Hankemeier, T., Moisan, A., & Vulto, P.
Affiliations
  • Mimetas (Netherlands) (NL)
  • F. Hoffmann-La Roche AG (CH)
  • Leiden University (NL)
Corresponding author
Vulto, Paul
Venue
Nature Communications
Published
2017-08-15
Volume
8
Issue
1
Pages
262-262
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2742210001
Cited by
290
References
22
Citations by year
2026: 15 · 2025: 31 · 2024: 42 · 2023: 34 · 2022: 35 · 2021: 41 · 2020: 36 · 2019: 25 · 2018: 29 · 2017: 2
FWCI
11.32
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Leiden Repository (Leiden University) (submittedVersion, other-oa)
  • Leiden Repository (Leiden University) (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Universiteit Leiden
  • Leids Universitair Medisch Centrum
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
intestinal epithelium, organ-on-a-chip, barrier integrity, leak detection, extracellular matrix, tissue polarization, transporter expression, adverse drug reactions, in vitro gut model, automated imaging
MeSH terms
Humans, Intestinal Mucosa, Kinetics, Cell Culture Techniques, Caco-2 Cells, Microfluidic Analytical Techniques, Lab-On-A-Chip Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes. https://app.cochat.ai/papers/10.1038/s41467-017-00259-3
The paper
Trietsch, S. J., Naumovska, E., Kurek, D., Setyawati, M. C., Vormann, M. K., Wilschut, K. J., Lanz, H. L., Nicolas, A., Ng, C. P., Joore, J., Kustermann, S., Roth, A., Hankemeier, T., Moisan, A., & Vulto, P. (2017). Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes. Nature Communications. https://doi.org/10.1038/s41467-017-00259-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.